NextCure, Inc.
NASDAQ:NXTC
0.8225 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 13.082 | 26.63 | 12.337 | 32.772 | 34.091 | 135.173 | 8.427 |
| Short Term Investments
| 95.217 | 133.281 | 207.254 | 250.676 | 300.514 | 0 | 0 |
| Cash and Short Term Investments
| 108.299 | 159.911 | 219.591 | 283.448 | 334.605 | 135.173 | 8.427 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | -0.7 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.426 | 4.072 | 8.226 | 4.53 | 5.39 | 0.612 | 0.993 |
| Total Current Assets
| 112.725 | 163.983 | 227.817 | 287.978 | 339.995 | 135.785 | 9.42 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 13.431 | 16.913 | 13.992 | 15.809 | 12.09 | 11.407 | 10.021 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 1.806 | 3.333 | 0 | 0 |
| Tax Assets
| 0 | 1.538 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.882 | 1.727 | 0.577 | 1.051 | 0.75 | 0.436 | 0.026 |
| Total Non-Current Assets
| 15.313 | 20.178 | 14.569 | 18.666 | 16.173 | 11.843 | 10.047 |
| Total Assets
| 128.038 | 184.161 | 242.386 | 306.644 | 356.168 | 147.628 | 19.467 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 2.33 | 4.27 | 1.942 | 3.901 | 1.861 | 2.483 | 1.141 |
| Short Term Debt
| 0.656 | 0.518 | 0 | 1.667 | 1.802 | 0.514 | 0.504 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0.13 | 6.428 | 4.989 | -0.504 |
| Other Current Liabilities
| 3.897 | 4.339 | 4.666 | 4.757 | 4.951 | 2.312 | 1.479 |
| Total Current Liabilities
| 6.883 | 9.127 | 6.608 | 10.325 | 15.042 | 10.298 | 3.124 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 5.949 | 13.21 | 0 | 1.806 | 3.333 | 0.073 | 0.46 |
| Deferred Revenue Non-Current
| 0 | -1.538 | 0 | 0 | 15.95 | 21.736 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 1.538 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.785 | -5.706 | 2.392 | 0.792 | 0.359 | 162.465 | 40.295 |
| Total Non-Current Liabilities
| 6.734 | 7.504 | 2.392 | 2.598 | 19.642 | 184.274 | 40.755 |
| Total Liabilities
| 13.617 | 16.631 | 9 | 12.923 | 34.684 | 194.572 | 43.879 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 356.168 | 162.223 | 40 |
| Common Stock
| 0.028 | 0.028 | 0.028 | 0.028 | 0.027 | 0.011 | 0.011 |
| Retained Earnings
| -324.482 | -261.759 | -187.026 | -117.637 | -81.034 | -47.297 | -24.498 |
| Accumulated Other Comprehensive Income/Loss
| -0.222 | -1.494 | -0.663 | 0.779 | -0.038 | -2.469 | -0.792 |
| Other Total Stockholders Equity
| 439.097 | 430.755 | 421.047 | 410.551 | 402.529 | -159.734 | -39.208 |
| Total Shareholders Equity
| 114.421 | 167.53 | 233.386 | 293.721 | 321.484 | -46.944 | -24.412 |
| Total Equity
| 114.421 | 167.53 | 233.386 | 293.721 | 321.484 | -46.944 | -24.412 |
| Total Liabilities & Shareholders Equity
| 128.038 | 184.161 | 242.386 | 306.644 | 356.168 | 147.628 | 19.467 |